Summary of our market study

French homeopathy market estimated at 400 million euros

The global homeopathy market has experienced strong growth and is set to continue expanding, rising from US$6.20 billion to US$19.78 billion between 2020 and 2030.

The French homeopathy market, despite the challenges posed by the total de-reimbursement by the French social security system in 2021, has resumed its growth. The Boiron group has forecast a 17% increase in sales in 2022, after a 50% drop in sales due to the delisting.

Exports of homeopathic products from France have remained stable in value terms, with the USA and Belgium being important markets, while Germany, Ireland, the USA and Switzerland account for over 50% of French imports.

The French market has long been a stronghold for homeopathic remedies.

Since delisting, the market has adapted. Leading homeopathic players, such as Laboratoires Boiron and Lehning, have diversified their offering to include probiotics, dietary supplements and health tests for influenza and Covid-19.

The average French user has been taking homeopathic treatments for around twenty years.

Some 20,000 general practitioners prescribe homeopathy on a daily basis, but only a minority specialize in this field. More than 50 hospital consultations offer homeopathic treatments.

It is thought that increased use of homeopathy could reduce reliance on more conventional medicines, which could lower healthcare costs. For specific health problems such as respiratory infections, musculoskeletal pain and psychological disorders, homeopathy could halve or even triple the use of conventional medicines.

Homeopathy market players

  • Laboratoires Boiron fest one of the leaders in homeopathy.

  • Rocal homeopathy, part of the Lehning group, is another benchmark in homeopathic treatments.

  • Weleda offers not only homeopathic remedies, but also a wider range of natural health and wellness products...

  • TP Santé (Cegedim group) and Mon Conseil Pharma (Carte Blanche Partenaires group) have focused their efforts on developing platforms and partnerships that facilitate access to homeopathic remedies.

Get all the information you need
to understand this market

Detailed content of our market study

Inforamtion

  • Number of pages : ~ 40 pages
  • Format : Digital and PDF versions
  • Last update :

Summary and extracts

1 Market overview

1.1 Definition and scope of study

Homeopathy is a concept created in 1796 by the German physician Samuel Hahnemann. It is based on the idea thata substance that causes a symptom can be used to treat the same symptom of disease. Practitioners of homeopathy believe it works by stimulating the body to heal itself. This practice is based on 3 essential principles[Ministère de la Santé et de la Prévention] :

  • similarity: what can make you ill in high doses can cure you in low doses.
  • infinitesimality : remedies are prepared from active substances called "strains", taken from the plant, mineral and animal kingdoms, using successive Hahnemannian or Korsakovian dilution techniques.
  • the principle of individualization: the approach takes into account not only the symptoms associated with a person's illness, but also their physical and psychological particularities.

The global homeopathy market is estimated to be worth 7.82 billion dollars by 2022. It has grown strongly in recent years and should continue to do so over the next seven years. Europe is currently the leading market for this alternative medicine, followed by North America and Asia. However, it is on the latter continent that sales growth is expected to be most significant, due to the full market entry of the largest Asian homeopathic laboratories. France, meanwhile, is one of the leading consumer countries for homeopathy, with an estimated 77% of French people having used this form of treatment by 2018. [Ipsos]. France is therefore home to a mature market with consumers who are loyal to and educated about homeopathy.

The French market is dominated by long-established players such as the Boiron laboratory, which holds over 50% of market share[Capital], and the Lehning laboratory. Other groups have entered this market more recently, such as the Gilbert group, traditionally specialized in children's health and cosmetics.

Homeopathy has seen its position as an ideal complement to traditional medicine called into question, due to the decision taken in 2019 by Agnès Buzyn, then Minister of Health, to reduce in 2020 and then stop in 2021 the reimbursement of homeopathic treatments by Social Security. Whereas previously many of these treatments were reimbursed at up to 30%, they are now not reimbursed at all from January1, 2021.

As a result, the market suffered a significant drop in volume in 2020 and 2021, which was then partially offset by a rise in treatment prices, and a diversification of activities by major market players (probiotics, dietary supplements, flu tests and Covid-19). Boiron, for example, saw its sales increase by 17% in 2022, after having been divided by 2 between 2019 and 2021. [Challenges]

1.2 Global market

The global homeopathy market is growing rapidly, and is expected to increase by **.*% between **** and ****, from US$*.** billion to US$**.** billion.

sales trends in the homeopathy market World, ****-****, in US$ billion Source: ****

This increase in sales is due to the expansion of this product into more and more markets, whether for those suffering from chronic illnesses or those looking for natural, gentle preventive or curative products. The market is also boosted by online sales. However, the restrictive regulation of this type of product is hampering growth potential.

1.3 Domestic market

In ****, Le Monde estimated the weight of the homeopathy market at *.**% of drug sales by value. That's *** million euros, out of a drug market worth **.* billion euros. We will assume that this share remains unchanged over the ****-**** period.

However, according to the French Pharmaceutical Companies Association (***), sales on the pharmaceutical market rose from €**.* billion to €**.* billion between **** and ****. This would correspond to a homeopathy market of *** million in ****.

However, the sector saw a sharp drop in ****, and again in ****, due to the cyclical reduction in winter pathologies and the new regulations on homeopathy in France. To estimate the fall in the sector's revenues, we will rely on data relating to the sector's giant, Boiron, which enjoys a virtual monopoly on the French market. In ****, its market share is estimated at over **%[***]. However, that same year, the company predicted that delisting would lead to a **% drop in sales in **** on previously reimbursed products(***) in the sector's sales. This decline needs to be qualified, however, as the drop in volume may be offset by a rise in prices, although this is unlikely given that these products are already relatively expensive. Boiron could also rely on exports.

In ****, two years after the implementation ...

1.4 International trade

In the CN* nomenclature, homeopathy is included in the category"******** - Medicinal products consisting of mixed or unmixed products, prepared for therapeutic or prophylactic purposes, and put up in measured doses (***)."

However, this data needs to be analyzed with a critical eye, as the category also includes other alternative pharmaceutical products, notably herbal.

trade balance trends France, ****-****, in billions of euros Source: ****

In ****, exports by value amounted to **.* billion euros, compared with **.* billion euros for imports. The coverage rate remained more or less unchanged between **** and ****.

Export destination by country France, ****, % of total Source: ****

In terms of exports, the USA (***) are major markets for alternative pharmaceutical products such as homeopathy. Outside these countries, however, France trades with a wide range of players, all of which account for less than **% of its outlets.

Origin of imports by country France, ****, % of imports Source: ****

Imports are already more concentrated, with * countries accounting for over **% of French imports of homeopathic and similar products: Germany (***).

1.5 Growth slowed by the health crisis and total delisting of reimbursements

While the sector saw its sales slow in **** due to the health crisis, characterized by a sharp decline in winter illnesses, it was further disrupted by the delisting of its products from January *, ****. The study by Boiron, the world leader in homeopathy, is significant in this respect. Its sales fell by -**% in the first half of ****. Sales fell by **%, from *** million euros in the first half of **** to *** million euros over the same period in ****.

evolution of Boiron Group net income and net loss France, ****-****, in millions of euros Source: ****

Boiron has therefore had to review its entire industrial strategy in order to adapt to this new context. In ****, ** million euros of the Group's sales were generated by the sale of self-tests. Internationalization and therapeutic cannabis are two other possible resilience strategies for players in the sector. [***]

2 Demand analysis

2.1 A well-established French consumer practice

Health, at the heart of French people's concerns

At the heart of the **** presidential campaign, **% of French people ranked healthcare as one of the priorities to be addressed by politicians, second only to purchasing power [***].

These figures are the result of a sharp rise in demand for healthcare and medical goods in France. Indeed, their consumption is growing steadily. It has risen from ***.* billion euros in **** to ***.* billion euros in ****, according to a DREES study. We can therefore conclude that the French are increasingly concerned about their health.

Consumption of healthcare and medical goods France, ****-****, in billions of euros DREES - Vie Publique

The French believe in the efficacy of homeopathy

A **** Ipsos study reveals that the French have been using homeopathy regularly for an average of ** years (***), with a total of **% having already tried it in ****.

assessment of the French relationship with homeopathy France, ****, % Source: ****

However, practice is stagnating

Homeopathy made its way into French habits at the turn of the century, surpassing the **% user mark in ****. Since then, consumption has stagnated.

trend in homeopathic medicine consumption in France France, ****-****, in % Source: ****

2.2 Popular with the French, but not with healthcare professionals

Homeopathy tops the list of therapies favored by the French [***] The barometer dates from ****, but this gap still exists in ****.

assessment of the gap between patients and doctors on the question of homeopathy France, ****, % Source: ****

This result is significant, even though in ****, **% of French people had confidence in healthcare professionals.[***]

2.3 The French appreciate alternative medicine

Harris interactive conducted a study for Santéclair on "The French and alternative medicine", in ****. The proportion of French people who said they had a good image of alternative medicine was **%, with an over-representation of women and affluent categories. These practices are considered better for the body and the environment than traditional medicine, but more expensive (***). They are associated with a more "natural" medicine, based on the use of "plants" and "essential oils". The best known are osteopathy, homeopathy and dietetics .

evaluation of French people's perception of alternative medicine France, ****, % Source: ****

2.4 Homeopathy to reduce healthcare costs

Homeopathy would be in the interest of public health, insofar as the demand for homeopathic products would reduce the demand for heavier drugs. In particular, it could reduce the demand for iatrogenic drugs by a factor of * or *.

For cases of equivalent severity and similar clinical results, homeopathy can be used[***] :

In the case of upper respiratory tract infections, a -**% reduction in the use of antibiotics; In the case of musculoskeletal pain, a -**% reduction in the use of non-steroidal anti-inflammatory drugs; In the case of sleep disorders, anxiety and depression, a -**% reduction in the use of psychotropic drugs.

In addition, homeopathy is most often prescribed by general practitioners as a preventive tool for recurrent health problems.

Complementary care in oncology

* in * oncologists declare an interest in homeopathy as supportive care. It is the *st complementary therapy in supportive care. Among cancer patients who use homeopathy, **% use it, and **% recognize its effect on pain, nausea and vomiting, and **% on fatigue.

evaluation of the value of homeopathy as supportive care in oncology France, ****, % Source: ****

Treatment adapted to the most fragile patients

The elderly and people with multiple medications are the most sensitive to drug side effects. The use of ...

3 Market structure

3.1 Overview of players

While **,*** general practitioners prescribe homeopathy every day, only *,*** are experts in the field. [***]

According to an Ipsos survey published by Boiron, in ****, those who prescribe the most homeopathy on a daily basis are midwives (***) sell homeopathy on a daily basis.

evaluation of homeopathic practice by healthcare professionals France, ****, % Source: ****

Laboratory involvement by type of homeopathic medicine

There are * types of homeopathic medicines[***] :

Common name: these medicines include common name strains, standard prescription formulas and homeopathic magistral preparations. They can be manufactured by homeopathic laboratories, provided they comply with the marketing standards set out in current regulations. They have no therapeutic indication, dosage or leaflet, so it's up to the health professional to determine them for each patient.

Brand-name or homeopathic specialties: products specifically developed by homeopathic laboratories and marketed under brand names such as Camilia® or Angipax®. They generally contain a combination of several active ingredients. They have a therapeutic indication, a dosage and are accompanied by a leaflet, making them suitable for self-medication.

3.2 Manufacturing homeopathic products

Homeopathic products come in a variety of forms: granules, syrups and sachets. They are made mainly from plants, but also from minerals, animal matter or chemicals. [***]

Nature of active product by origin France, ****, % Source: ****

These extracts are chosen according to the symptoms they produce, since the homeopathic method consists in "curing evil with evil" by ingesting a medicine that produces the same symptoms as the disease it aims to cure. However, the active ingredient is diluted many times over to prevent the patient from actually suffering the symptoms.

The manufacturing stages are as follows[***]:

Selection of suitable plants or other extracts; Preparation of the "mother tincture", i.e. the basic substance made up of plants, animal matter or chemicals; Dilution of one drop of the base solution in ** drops of alcoholic water; Dynamize the solution by shaking; Repeat steps *. and *. a dozen times Spray onto granules Place in tube.

Once the solution is ready, it is packaged, usually in the form of granules. After all these dilutions, only an infinitesimal trace of the active substance remains in the final homeopathic product. Before being marketed, the product must meet three conditions:

It must be intended for oral administration; It must have no ...

4 Offer analysis

4.1 Product offering typology

Average prices for tubes of homeopathic granules are summarized in the following table[***]:

The price of homeopathic granules is now set freely by the laboratories. Prices have been rising steadily since homeopathy was completely de-reimbursed on January *, ****. Some professionals are talking about an increase of up to **% in the price of homeopathy, compared to before the reform[***]

Homeopathic products also exist in other forms: drinking solution, drops, tablets, ointments, suppositories and syrups. [***]

4.2 Complementary health care offers and services integrating homeopathy

All contracts include homeopathic cover. What's more, ***% of mid-range contracts include a"well-being package". Finally, complementary health insurance covers €*.** per unit of homeopathic medicine prescribed.

In addition, complementary health insurance is supported by a number of services:

Homeo and prevention" webinar for policyholders; Teleconsultation with a homeopathic doctor; Editorial content and newsletter reserved for policyholders.

Source: ****

4.3 Development of easy management solutions

While homeopathy has been de-reimbursed since January *, ****, three types of players are increasingly calling for a new formula to frame the sector's offerings:

Complementary healthcare ; Patients; Pharmacists. [***]

The main offers already in place are those proposed by the Organismes de Tiers-Payant (***) Cégédim and Carte Blanche Partenaire, with the TP Santé and Mon Conseil Pharma tools respectively.

Source: ****

5 Regulations

5.1 Regulations

Article **** of the European Pharmacopoeia stipulates that the name given to a homeopathic preparation is usually the Latin name of the strain used, accompanied by the degree of dilution it has undergone. The French pharmacopoeia lists a number of homeopathic preparations, some examples of which are given below:

Abbies nigra PPH / Black fir PPH ; Causticum PPH ; Chrysanthellum americanum PPH ; Damiana PPH ; Moscus PPH.

Requirements for marketing homeopathic medicines

Since ****, European Directive ****/**/EC relating to all medicinal products for human use has defined the prerequisites for marketing homeopathic medicines. It distinguishes between two authorization procedures:

Registration according to mode of administration, degree of dilution and therapeutic indication. Marketing authorization (***).

Before January *, ****, homeopathic medicines were reimbursed by the French social security system, so their price was fixed. Following the delisting, it is now up to laboratories and pharmacies to set the price.

Reimbursement for homeopathic medicines

The decision to no longer reimburse homeopathic medicines by Social Security was taken after an in-depth analysis conducted by the Haute Autorité de Santé (***) in June ****. This decision is based on several important findings:

The lack of seriousness of certain benign conditions, where homeopathy is not necessary. The absence of evidence of efficacy in the conditions studied, ...

6 Positioning the players

6.1 Segmentation

  • Boiron
  • Weleda
  • Laboratoires Lehning
  • Cegedim
  • Carte Blanche Partenaires
  • Juvamine (Urgo Groupe)

All our studies are available online in PDF format

Take a look at an example of our research on another market!

Do you have a question about this study?   +44 238 097 0676

Choosing this study means :

Access to more than 35 hours of work

Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.

Benefit from 6 years' experience and over 1,500 industry reports already produced

Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.

Our know-how and methodology enable us to produce reports that offer unique value for money.

Access to several thousand articles and paid-for data

Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).

To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)

Guaranteed support after your purchase

A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676

A digital format designed for our users

Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.

Our offers :

the homeopathy market | France

99 €
  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What is the positioning of companies in the value chain?
  • Data from several dozen databases

Pack 5 études (-25%) France

74 € / study
370 € instead of 495 € -25%
  • 5 études au prix de 74 €HT par étude à choisir parmi nos 1200 titres sur le catalogue
  • Conservez -25% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez notre catalogue d’études sectorielles

 

Our customer references

They have consulted our studies Discover the opinions (+500)

Malcolm Vincent
Linkedin logo

Malcolm Vincent

Astoria Finance

Gregoire de Castelnau
Linkedin logo

Gregoire de Castelnau

Stags Participations

Timothé Huignard
Linkedin logo

Timothé Huignard

PWC

Paul-Alexis Kebabtchieff
Linkedin logo

Paul-Alexis Kebabtchieff

BCG

Aymeric Granet
Linkedin logo

Aymeric Granet

Publicis Consultant

interviews & case studies All interviews and case studies (45)

La pépite Interview

BFM Business

Paul-Alexis Kebabtchieff

Boston Consulting Group

Marie Guibart

Kea Partners

Elaine, Durand

Crédit Agricole, Information & Veille

Philippe Dilasser

Initiative & Finance

Anne Baudry

Metro

Amaury Wernert

Kroll (Duff & Phelps)

Smart Leaders Interview

B-Smart

Do you have a question ?
Our team is at your disposal at   +44 238 097 0676